MiR-506 Promotes Antitumor Immune Response in Pancreatic Cancer by Reprogramming Tumor-Associated Macrophages toward an M1 Phenotype

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer with a poor prognosis, and effective treatments for PDAC are lacking. In this study, we hypothesized that miR-506 promotes antitumor immune response in PDAC by reprogramming tumor-associated macrophages toward an M1 phenotype to re...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Tiantian, Han, Yitong, Chen, Junhang, Liang, Xiaoyu, Sun, Longhao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669181/
https://www.ncbi.nlm.nih.gov/pubmed/38001876
http://dx.doi.org/10.3390/biomedicines11112874

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669181/
https://www.ncbi.nlm.nih.gov/pubmed/38001876
http://dx.doi.org/10.3390/biomedicines11112874

Ejemplares similares